Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Tumour-naïve ctDNA analysis in resected colorectal cancer in the phase III ASCOLT trial

ESMO Congress 2022